Global Antibiotic Research & Development Partnership (GARDP)

The Global Antibiotic Research & Development Partnership (GARDP) accelerates the development and access to treatments for drug-resistant bacterial infections. Together with public, private, and non-profit partners, GARDP works to preserve the power of antibiotics for generations to come. Based in Geneva, Switzerland, GARDP is committed to carrying out antibiotic R&D in regions heavily affected by drug resistance and to ensuring that approved treatments in our portfolio reach patients in those regions. With our co-founder and alliance partner DNDi, we have a cost-efficient global network.